Clinical trial
Observational Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
NCT04657887 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Registry of Patients With Von WilLEbrand Disease Treated With Voncento®
- Lead sponsor
- CSL Behring
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 23, 2015
- Completion date
- December 31, 2023
- Enrollment
- 135 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
von willebrand disease